NQO1 deficient triple-negative breast cancer (TNBC) MDA-MB-231 cells were also inherently resistant to KP372-1, with or without the PARPi rucaparib (Figure 1J). This evidence concerns the gene NQO1 and triple-negative breast carcinoma.